Bone Disease, Metabolic

3

Review clinical trials related to Bone Disease, Metabolic. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Elucidating the Minimal Effective Dose of Prunes for Bone Health in Postmenopausal Women

The objective of this study is to examine if calcium and vitamin D supplements and/or prune can prevent bone loss in postmenopausal women.

Participants needed: 200
Trial details
Biological sex: FemaleType: InterventionalSponsor: San Diego State UniversityUpdated: Jul 1, 2026Locations: 1
Eligibility criteria

Postmenopausal [+2]

Women whose BMD t-score at any site falls below 2.5 SD of the mean [+3]

Status: Recruiting

Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA)

Glucose-dependent insulinotropic polypeptide (GIP) is released by the intestines in response to food intake and increases insulin secretion. Although short-term (\< 3 hours) stimulation with GIP decreases bone resorption in humans, the effect may vanish following continuous administration within 24 hours, at least in patients with type 1 diabetes. Whether the anti-resorptive effect of GIP can be maintained if the hormone is non-continuously administrated is unclear. As the first GIP receptor (GIPR) agonist, tirzepatide was recently approved for the treatment of obesity and type 2 diabetes in the USA and type 2 diabetes alone in the EU, there is a need to establish knowledge about the long-term effects of GIP on bone health, including if different exposure times to GIP have different skeletal effects. This project will investigate whether GIP maintains its anti-resorptive potential if given as intermittent compared to continuous infusion in healthy men and women aged 18-40 years. Administration cycles involve intermittent (8 hours daily) and continuous (24 hours daily) injection of GIP for three days each. The effect of GIP will be measured by bone markers in blood samples, as well as in vitro activity and genetic alterations of bone cells (osteoclasts and osteoblasts) using bone marrow aspirates and bone marrow biopsies. Each participant will receive both administration cycles using a crossover design with a 14-28 days washout period between administrations of GIP.

Participants needed: 12
Trial details
Age: 18-40Biological sex: AllType: InterventionalSponsor: Esbjerg Hospital - University Hospital of Southern DenmarkUpdated: Jan 2, 2026Locations: 1
Eligibility criteria

healthy volunteers

pre-diabetes or diabetes (HbA1c >42mmol/mol) [+4]

Status: Recruiting

Metabolic Profile of Bone in Professional Athletes

Physical activity is a key stimulus for bone metabolism through both direct mechanisms (e.g., as a result of the applied load and/or impact) and indirect mechanisms (e.g., the activation of several metabolic pathways and the production of several mediators and effectors that have systemic effects). However, different kinds of physical activity exert different effects on bone and endocrine system. Aim of the study is to investigate the effects of different kinds of physical activity on bone metabolism and on the relationships existing between bone metabolism, energy metabolism, hormone profile, and organ functionality.

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioUpdated: Sep 11, 2025Locations: 1
Eligibility criteria

>/= 18 yo [+2]

< 18 yo [+9]